77 filings
Page 3 of 4
8-K
sm3iblw 1v6
5 Jan 21
Entry into a Material Definitive Agreement
4:49pm
8-K/A
8bzztbihha
4 Jan 21
Departure of Directors or Certain Officers
4:32pm
8-K
9w3gvnjm0
11 Dec 20
Departure of Directors or Certain Officers
4:01pm
8-K
jxx yjlh48bpa2wv
2 Nov 20
Rhythm Pharmaceuticals Reports Third Quarter 2020 Financial Results
9:32am
8-K
i6w 3a34u
16 Sep 20
Departure of Directors or Certain Officers
4:01pm
8-K
7yvtdi
3 Aug 20
Rhythm Pharmaceuticals Reports Second Quarter 2020 Financial Results
9:25am
8-K
s0x8 geamg7pyq2
21 Jul 20
Entry into a Material Definitive Agreement
5:15pm
8-K
vgcv4s b8
18 Jun 20
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
ogqt3 2mjpdi5amw
30 Mar 20
Departure of Directors or Certain Officers
5:20pm
8-K
nagmf07e9i0
2 Mar 20
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
4:51pm
8-K
uxxjbx9qs0mvq
26 Feb 20
Entry into a Material Definitive Agreement
4:08pm
8-K
xnwydewsbhujxg6n38a
10 Jan 20
Regulation FD Disclosure
8:46am
8-K
tcx3 g15kz9
8 Jan 20
Rhythm Pharmaceuticals Announces Leadership Transition
4:00pm
8-K
9dgxfv1
6 Nov 19
Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
9:28am
8-K
leia1xn
1 Nov 19
Rhythm Pharmaceuticals Reports Third Quarter 2019 Financial Results
4:22pm
8-K
617az
16 Oct 19
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
5:27pm
8-K
t2q2m4m
15 Oct 19
Results of Operations and Financial Condition
4:52pm
8-K
lneqmox
25 Sep 19
Rhythm Pharmaceuticals Provides Update on Research and Development Programs
8:30am
8-K
qttyqggurzcw2b6dut
7 Aug 19
Other Events
9:07am
8-K
cxopfebs
29 Jul 19
Regulation FD Disclosure
4:40pm